Bids Are Invited For Acquisition Of Controlled Medicines

Pharmacological Group: Announces And Inhibitors Of Gastric Secretary, Active Principle: Misoprostol, Pharmaceutical Form: Vaginal Compressed, Concentration / Dosage: 25, Unit: Mcg, Volume: Not Applied: Not Applied, Accessory: Not Applied, Pharmacological Group: Antipsychotic, Active Principle: Haloperidol Dean, 70, 52Mg / Ml, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 50, Unit: Mg, Volume: 1Ml, Presentation: Ampoule, Pharmacological Group: Anticonvulsants, Active Principle: Clonazepam, Pharmaceutical Form: Compressed, Concentration / Dosage: 0, 5, Pharmaceutical Form: Oral Solution: 2, Unit: 2, Unit: Mg/Ml, Volume: 20Ml, Presentation: Bottle Drops, Pharmacological Group: Analgesic Opioids, Active Principle: Codeine Phosphate+Paracetamol, Concentration/Dosage: 30+500, 12/05/2025, Pharmacological Group: Annsiolitic And Hypnosisading, Active Principle: Diazepam, Concentration/Dosage: 5, Volume: 5 2Ml, Pharmacological Group: Narcotic Analgesic, Active Principle: Methadone Hydrochloride, Concentration / Dosage: 10, Concentration / Dosage: 200, Active Principle: Remifentany Hydrochloride, Pharmaceutical Form: Po Liophilo Injectable, Presentation: Vial, Active Principle: Topiramatic Form: Pharmacological: General Anesthesic, Active Principle: Sevoflurane, Pharmaceutical Form: Inhalation Solution, Volume: 100 Ml, Introduction, Active Principle: Valproate De Sodio / Valproic Acid, Pharmaceutical Form: Syrup, Concentration / Dosage: 50Mg / Ml, Pharmaceutical Form: Capsule, Concentration / Dosage: 250 Mg, 250 Mg, 250 Mg, 250 Mg, 250 Mg, 250 Mg, 250 Mg, 250 Mg, 250 Mg, 250 Mg N/A, Presentation: N/A, Accessory: N/A, Pharmacological Group: General Anestesic, Active Principle: Propofol, Pharmaceutical Form: Solution, Unit: Mg/Ml, Volume: 20 Ml, Form Supply: Ampolo Bottle